A US lawmaker has called for expanding restrictions on American research funding to cover additional Chinese universities, according to a report carried by Internazionale. The proposal, if advanced, would widen the list of Chinese schools whose researchers are barred from — or limited in — accessing US federal research money.

The underlying report consists of a headline-level item; no sponsor name, target institutions, funding amounts or legislative vehicle appear in the available text. That absence matters for R&D managers: the practical scope of any curb — which agencies, which universities, which grant mechanisms — remains undefined in the public item.

Why does this matter for research portfolios?

Existing US restrictions on Chinese institutions have already shaped collaboration decisions at universities and national laboratories. Extending the covered list would touch:

• Co-authorship and co-investigator arrangements with affected institutions
• Equipment purchases and materials transfers subject to export and funding rules
• Grant renewals where a partner institution becomes newly restricted

Until the proposing lawmaker names the schools and the mechanism, portfolio teams cannot price the compliance burden. Institutions currently rely on agency-level guidance and Department of Defense-designated restricted lists; any expansion would require new rulemaking or legislation.

What is confirmed — and what is not

Confirmed: a US legislator has publicly called for broadening research-funding curbs to more Chinese schools. Not confirmed from this item: the lawmaker's identity, the number of additional schools proposed, the funding agencies in scope, or any timeline.

Managers tracking US–China research policy should watch for the follow-on bill text or committee referral, which will convert this call into auditable rules.